Skip to Main Content

Author Details

Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
1979
201
55
PMIDPaper TitleJournal TitlePublished Year
37435060High infiltration of CD209<sup>+</sup> dendritic cells and CD163<sup>+</sup> macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.Front Immunol2023
37190147Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.Cancers (Basel)2023
35751441Impact of artificial intelligence on pathologists' decisions: an experiment.J Am Med Inform Assoc2022
34743445Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.J Biomed Opt2021
34575920Identification of Abundant and Functional dodecaRNAs (doRNAs) Derived from Ribosomal RNA.Int J Mol Sci2021
32797086Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.PLoS Med2020
30819787Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody.Drug Metab Dispos2019
30113732Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer.BJU Int2019
30136199The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer.World J Urol2019
31315273Omega-3 Fatty Acids Survey in Men under Active Surveillance for Prostate Cancer: from Intake to Prostate Tissue Level.Nutrients2019
31220149Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.PLoS One2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
30987833Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancer.Pathol Res Pract2019
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
30889379The Proteogenomic Landscape of Curable Prostate Cancer.Cancer Cell2019
29102166Association between physical activity and the expression of mediators of inflammation in normal breast tissue among premenopausal and postmenopausal women.Cytokine2018
30131069HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis.Diagn Pathol2018
30223832Correction to: HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis.Diagn Pathol2018
29764106The Challenges of a Complex and Innovative Telehealth Project: A Qualitative Evaluation of the Eastern Quebec Telepathology Network.Int J Health Policy Manag2018
28002200Association between expression of inflammatory markers in normal breast tissue and mammographic density among premenopausal and postmenopausal women.Menopause2017
28511883A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.Eur Urol2017
28846716Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients.PLoS One2017
27903840Evaluation of Antioxidant Intakes in Relation to Inflammatory Markers Expression Within the Normal Breast Tissue of Breast Cancer Patients.Integr Cancer Ther2017
28049773Cross-Talk between Alternatively Spliced UGT1A Isoforms and Colon Cancer Cell Metabolism.Mol Pharmacol2017
27815082Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.Eur Urol2017
28068672Genomic hallmarks of localized, non-indolent prostate cancer.Nature2017
26215610The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer Progression.Eur Urol2016
26252758Impacts of a Large Decentralized Telepathology Network in Canada.Telemed J E Health2016
26594800A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.Oncotarget2016
27571273Association of Telomere Length with Breast Cancer Prognostic Factors.PLoS One2016
25771900Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.Hum Pathol2015
26070608Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy.Diagn Pathol2015
26005866Spatial genomic heterogeneity within localized, multifocal prostate cancer.Nat Genet2015
25710783Physical activity, mammographic density, and age-related lobular involution among premenopausal and postmenopausal women.Menopause2015
25731206Low level of the X-linked ribosomal protein S4 in human urothelial carcinomas is associated with a poor prognosis.Biomark Med2015
23802851Canadian licensure for the use of digital pathology for routine diagnoses: one more step toward a new era of pathology practice without borders.Arch Pathol Lab Med2014
25564940The Eastern Québec Telepathology Network: a three-year experience of clinical diagnostic services.Diagn Pathol2014
25564778Online teaching of inflammatory skin pathology by a French-speaking International University Network.Diagn Pathol2014
25171705Telepathology for intraoperative consultations and expert opinions: the experience of the Eastern Québec Telepathology Network.Arch Pathol Lab Med2014
25132434[The Canadian Association of Pathology guidelines for establishing a diagnostic telepathology service using whole-slide imaging].Ann Pathol2014
24824038Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance.Cancer Prev Res (Phila)2014
24843826Guidelines from the Canadian Association of Pathologists for establishing a telepathology service for anatomic pathology using whole-slide imaging.J Pathol Inform2014
24603589Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis.Mod Pathol2014
24277450Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.Clin Cancer Res2014
22901983The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients.Eur Urol2013
24194978Strategies for biochemical and pathologic quality assurance in a large multi-institutional biorepository; The experience of the PROCURE Quebec Prostate Cancer Biobank.Biopreserv Biobank2013
23988418A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer.Gynecol Oncol2013
23743930Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.Mod Pathol2013
23574787High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.Hum Pathol2013
23331188Histological study of stem-like cells in human colon adenocarcinoma at different stages of the disease.Biotech Histochem2013
  • 1 - 50 of 201

Recommended Authors

INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 3
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1996
Number of shared co-authors 0
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
University of Southern California
Career Start Year 1995
Number of shared co-authors 3
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 9
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 9
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 22
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 3
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 4
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 2
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 0
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1986
Number of shared co-authors 13
University of Kansas
Career Start Year 1985
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1984
Number of shared co-authors 2
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 2
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 2
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 4
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 0
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 13
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 12
The Institute of Cancer Research
Career Start Year 1977
Number of shared co-authors 7
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 5
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1975
Number of shared co-authors 21
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 5
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 2

Collaborators

CHU de Quebec-Universite Laval
Co-authored papers 40
Laval University Cancer Research Center
Co-authored papers 28
CHU de Quebec-Universite Laval
Co-authored papers 24
Laval University
Co-authored papers 22
Institut du cancer de Montreal
Co-authored papers 20
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Co-authored papers 18
Laval University, CHU de Quebec
Co-authored papers 17
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 16
University Health Network, University of Toronto
Co-authored papers 16
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 12
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 9
University of California los angeles
Co-authored papers 9
University of Toronto
Co-authored papers 9
University of Montreal Health Center
Co-authored papers 6
University of California los angeles
Co-authored papers 6
Ontario Institute for Cancer Research
Co-authored papers 5
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 5
National Cancer Centre Singapore
Co-authored papers 5
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers 5
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Co-authored papers 5
Tufts University School of Medicine
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
McGill University Health Centre, McGill University
Co-authored papers 4
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 4
University of Toronto
Co-authored papers 4
University of British Columbia
Co-authored papers 4
Ontario Institute for Cancer Research
Co-authored papers 4
McGill University Health Centre, McGill University
Co-authored papers 4
University of California los angeles
Co-authored papers 4
McGill University Health Centre, McGill University
Co-authored papers 4